The importance of early treatment of the anaemia of chronic kidney disease

被引:21
|
作者
Eknoyan, G [1 ]
机构
[1] Baylor Coll Med, Dept Med, Renal Sect, Houston, TX 77030 USA
关键词
anaemia; cardiovascular diseased; chronic kidney disease; chronic renal failure; dialysis morbidity; dialysis mortality; epoetin; erythropoietin; kidney failure;
D O I
10.1093/ndt/16.suppl_5.45
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
The beneficial effects of treating the anaemia of dialysis-dependent patients with erythropoietin on the improvement of cardiac status, exercise capacity, cognitive function and quality of life are well established. Equally, if not more important is the reduction in morbidity and mortality that accompanies the treatment of anaemia with epoietin. These documented improvements in outcomes of care notwithstanding, mortality and morbidity due to cardiovascular disease (CVD) remain high in dialysis patients. Recent epidemiological evidence indicates that: (i) the prevalence of CVD is very high in patients at the start of dialysis (ii) pre-existing CVD is the major risk factor for mortality and morbidity on dialysis; (iii) CVD begins early in the course of kidney disease, shows an inverse relationship to kidney function and increases in prevalence and severity with progression of kidney disease; and (iv) corrective measures, which take 3-5 years to show a favourable effect, must be instituted well before the initiation of dialysis. Hypertension and anaemia, which develop in the course of progressive reduction in kidney function, are the principal risk factors for the prevalence of left ventricular hypertrophy (LVH) in those with chronic kidney disease, and their treatment has been shown to arrest or reverse LVH in these individuals. Whereas the treatment of hypertension early in the course of kidney disease has been incorporated into clinical practice, there has been reluctance in the treatment of anaemia because of the possibility of worsening kidney function with epoietin, as shown in rats. There is now convincing evidence that epoietin has no potential adverse effect on kidney function in humans. While the most compelling reason for the early treatment of the anaemia of kidney disease is its beneficial effect on cardiovascular function, other documented potential benefits are improvements in exercise capacity, cognitive function and quality of life.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 50 条
  • [1] Roxadustat in the treatment of anaemia in chronic kidney disease
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (01) : 125 - 133
  • [2] The importance of early detection of chronic kidney disease
    Locatelli, F
    Del Vecchio, L
    Pozzoni, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 : 2 - 7
  • [3] Anaemia in chronic kidney disease
    van Hougenhouck-Tulleken, W.
    SA PHARMACEUTICAL JOURNAL, 2023, 90 (01) : 22 - 24
  • [4] The importance of early referral for the treatment of chronic kidney disease: a Danish nationwide cohort study
    Kristine Hommel
    Mette Madsen
    Anne-Lise Kamper
    BMC Nephrology, 13
  • [5] The importance of early referral for the treatment of chronic kidney disease: a Danish nationwide cohort study
    Hommel, Kristine
    Madsen, Mette
    Kamper, Anne-Lise
    BMC NEPHROLOGY, 2012, 13
  • [6] Darbepoetin for the anaemia of chronic kidney disease
    Palmer, Suetonia C.
    Saglimbene, Valeria
    Craig, Jonathan C.
    Navaneethan, Sankar D.
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (03):
  • [7] Anaemia in chronic kidney disease pregnancy
    Morton, Adam
    Burke, Michael
    Morton, Anthony
    Kumar, Sailesh
    OBSTETRIC MEDICINE, 2021, 14 (02) : 116 - 120
  • [8] Managing the anaemia of chronic kidney disease
    Roger, Simon D.
    AUSTRALIAN PRESCRIBER, 2009, 32 (05) : 129 - 131
  • [9] The importance of patient education in the treatment of chronic kidney disease
    Fox, Chester
    Kohn, Linda S.
    KIDNEY INTERNATIONAL, 2008, 74 (09) : 1114 - 1115
  • [10] New treatment approaches in chronic kidney disease-associated anaemia
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 687 - 696